Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics ...Middle East

PR Newswire - News
TULSA, Okla., Jan. 10, 2023 /PRNewswire/ -- FortySix Venture Capital LLC (46VC) and The University of Tulsa (TU) announced today that technology developed by TU researchers has been licensed by 46VC for commercialization efforts. Researchers at The University of Tulsa have developed a...

Hence then, the article about technology developed at the university of tulsa and licensed by fortysix venture capital could advance cancer testing and targeted therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Technology developed at The University of Tulsa and licensed by FortySix Venture Capital could advance cancer testing and targeted therapeutics )

Apple Storegoogle play

Last updated :

Also on site :